Weiping Zou - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Immunology, Cell Biology, Molecular Biology

92 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Wang W, Green M, Choi JE, Gijón M, Kennedy PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, Xia H, Zhou J, Li G, Li J, Li W, ... ... Zou W, et al. CD8 T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. PMID 31043744 DOI: 10.1038/s41586-019-1170-y  0.56
2018 Lazarus J, Maj T, Smith JJ, Perusina Lanfranca M, Rao A, D'Angelica MI, Delrosario L, Girgis A, Schukow C, Shia J, Kryczek I, Shi J, Wasserman I, Crawford H, Nathan H, ... ... Zou W, et al. Spatial and phenotypic immune profiling of metastatic colon cancer. Jci Insight. 3. PMID 30429368 DOI: 10.1172/jci.insight.121932  0.56
2018 Wu YM, Cieślik M, Lonigro RJ, Vats P, Reimers MA, Cao X, Ning Y, Wang L, Kunju LP, de Sarkar N, Heath EI, Chou J, Feng FY, Nelson PS, de Bono JS, ... Zou W, et al. Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer. Cell. 173: 1770-1782.e14. PMID 29906450 DOI: 10.1016/j.cell.2018.04.034  0.32
2018 Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, Wei S, Zhao L, Vatan L, Wen B, Shu P, Sun D, Kleer C, Wicha M, Sabel M, ... ... Zou W, et al. Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer. Cell Metabolism. PMID 29805099 DOI: 10.1016/j.cmet.2018.04.022  0.56
2018 Crespo J, Wu K, Li W, Kryczek I, Maj T, Vatan L, Wei S, Opipari AW, Zou W. Human Naive T Cells Express Functional CXCL8 and Promote Tumorigenesis. Journal of Immunology (Baltimore, Md. : 1950). PMID 29802127 DOI: 10.4049/jimmunol.1700755  0.56
2018 Lin H, Wei S, Hurt EM, Green MD, Zhao L, Vatan L, Szeliga W, Herbst R, Harms PW, Fecher LA, Vats P, Chinnaiyan AM, Lao CD, Lawrence TS, Wicha M, ... ... Zou W, et al. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression. The Journal of Clinical Investigation. 128: 1708. PMID 29608143 DOI: 10.1172/JCI120803  0.56
2018 Yan TT, Ren LL, Shen CQ, Wang ZH, Yu YN, Liang Q, Tang JY, Chen YX, Sun DF, Zgodziński W, Majewski M, Radwan P, Kryczek I, Zhong M, Chen J, ... ... Zou W, et al. MicroRNA-508 defines the stem-like/mesenchymal subtype in colorectal cancer. Cancer Research. PMID 29374066 DOI: 10.1158/0008-5472.CAN-17-2101  0.56
2018 Lin H, Wei S, Hurt EM, Green MD, Zhao L, Vatan L, Szeliga W, Herbst R, Harms PW, Fecher LA, Vats P, Chinnaiyan AM, Lao CD, Lawrence TS, Wicha M, ... ... Zou W, et al. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression. The Journal of Clinical Investigation. PMID 29337305 DOI: 10.1172/JCI96113  0.56
2017 Crespo J, Vatan L, Maj T, Liu R, Kryczek I, Zou W. Phenotype and tissue distribution of CD28H+ immune cell subsets. Oncoimmunology. 6: e1362529. PMID 29209568 DOI: 10.1080/2162402X.2017.1362529  0.56
2017 Xia H, Wang W, Crespo J, Kryczek I, Li W, Wei S, Bian Z, Maj T, He M, Liu RJ, He Y, Rattan R, Munkarah A, Guan JL, Zou W. Suppression of FIP200 and autophagy by tumor-derived lactate promotes naïve T cell apoptosis and affects tumor immunity. Science Immunology. 2. PMID 29150439 DOI: 10.1126/sciimmunol.aan4631  0.56
2017 Maj T, Wang W, Crespo J, Zhang H, Wang W, Wei S, Zhao L, Vatan L, Shao I, Szeliga W, Lyssiotis C, Liu JR, Kryczek I, Zou W. Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nature Immunology. PMID 29083399 DOI: 10.1038/ni.3868  0.56
2017 Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N, Chen Y, Chen H, Hong J, Zou W, Fang JY. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell. 170: 548-563.e16. PMID 28753429 DOI: 10.1016/j.cell.2017.07.008  0.56
2017 Fang M, Li Y, Huang K, Qi S, Zhang J, Zgodzinski W, Majewski M, Wallner G, Gozdz S, Macek P, Kowalik A, Pasiarski M, Grywalska E, Vatan L, Nagarsheth N, ... ... Zou W, et al. IL-33 promotes colon cancer cell stemness via JNK activation and macrophage recruitment. Cancer Research. PMID 28249897 DOI: 10.1158/0008-5472.CAN-16-1602  0.56
2016 Hu X, Liu X, Moisan J, Wang Y, Lesch CA, Spooner C, Morgan RW, Zawidzka EM, Mertz D, Bousley D, Majchrzak K, Kryczek I, Taylor C, Van Huis C, Skalitzky D, ... ... Zou W, et al. Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity. Oncoimmunology. 5: e1254854. PMID 28123897 DOI: 10.1080/2162402X.2016.1254854  0.56
2016 Kryczek I, Wang L, Wu K, Li W, Zhao E, Cui T, Wei S, Liu Y, Wang Y, Vatan L, Szeliga W, Greenson JK, Roliński J, Zgodzinski W, Huang E, ... ... Zou W, et al. Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma. Oncoimmunology. 5: e1105430. PMID 27622054 DOI: 10.1080/2162402X.2015.1105430  1
2016 Sun D, Lin Y, Hong J, Chen H, Nagarsheth N, Peng D, Wei S, Huang E, Fang J, Kryczek I, Zou W. Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling. Oncoimmunology. 5: e1082704. PMID 27622053 DOI: 10.1080/2162402X.2015.1082704  1
2016 Peng D, Tanikawa T, Li W, Zhao L, Vatan L, Szeliga W, Wan S, Wei S, Wang Y, Liu Y, Staroslawska E, Szubstarski F, Rolinski J, Grywalska E, Stanislawek A, ... ... Zou W, et al. Myeloid-derived suppressor cells endow stem-like qualities to breast cancer cells through IL-6/STAT3 and NO/NOTCH cross-talk signaling. Cancer Research. PMID 27197152 DOI: 10.1158/0008-5472.CAN-15-2528  1
2016 Sun TT, He J, Liang Q, Ren LL, Yan TT, Yu TC, Tang JY, Bao YJ, Hu Y, Lin Y, Sun D, Chen YX, Hong J, Chen H, Zou W, et al. A novel lncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern. Cancer Discovery. PMID 27147598 DOI: 10.1158/2159-8290.CD-15-0921  1
2016 Wang W, Kryczek I, Dostál L, Lin H, Tan L, Zhao L, Lu F, Wei S, Maj T, Peng D, He G, Vatan L, Szeliga W, Kuick R, Kotarski J, ... ... Zou W, et al. Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer. Cell. PMID 27133165 DOI: 10.1016/j.cell.2016.04.009  1
2016 Li Y, Fang M, Zhang J, Wang J, Song Y, Shi J, Li W, Wu G, Ren J, Wang Z, Zou W, Wang L. Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity. Oncoimmunology. 5: e1074374. PMID 27057439 DOI: 10.1080/2162402X.2015.1074374  0.32
2016 Perusina Lanfranca M, Lin Y, Fang J, Zou W, Frankel T. Biological and pathological activities of interleukin-22. Journal of Molecular Medicine (Berlin, Germany). PMID 26923718 DOI: 10.1007/s00109-016-1391-6  1
2015 Nagarsheth N, Peng D, Kryczek I, Wu K, Li W, Zhao E, Zhao L, Wei S, Frankel T, Vatan L, Szeliga W, Dou Y, Owens S, Marquez V, Tao K, ... ... Zou W, et al. PRC2 epigenetically silences Th1-type chemokines to suppress effector T cell trafficking in colon cancer. Cancer Research. PMID 26567139 DOI: 10.1158/0008-5472.CAN-15-1938  1
2015 Zhao E, Maj T, Kryczek I, Li W, Wu K, Zhao L, Wei S, Crespo J, Wan S, Vatan L, Szeliga W, Shao I, Wang Y, Liu Y, Varambally S, ... ... Zou W, et al. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nature Immunology. PMID 26523864 DOI: 10.1038/ni.3313  0.56
2015 Peng D, Kryczek I, Nagarsheth N, Zhao L, Wei S, Wang W, Sun Y, Zhao E, Vatan L, Szeliga W, Kotarski J, Tarkowski R, Dou Y, Cho K, Hensley-Alford S, ... ... Zou W, et al. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature. PMID 26503055 DOI: 10.1038/nature15520  1
2015 Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, Bonneville M, Butterfield LH, Caignard A, Castelli C, Cavallo F, Celis E, Chen L, Colombo MP, ... ... Zou W, et al. Consensus nomenclature for CD8(+) T cell phenotypes in cancer. Oncoimmunology. 4: e998538. PMID 26137416 DOI: 10.1080/2162402X.2014.998538  1
2015 Wan S, Kuo N, Kryczek I, Zou W, Welling TH. Myeloid cells in hepatocellular carcinoma. Hepatology (Baltimore, Md.). PMID 25914264 DOI: 10.1002/hep.27867  1
2014 Zhao HJ, Ren LL, Wang ZH, Sun TT, Yu YN, Wang YC, Yan TT, Zou W, He J, Zhang Y, Hong J, Fang JY. MiR-194 deregulation contributes to colorectal carcinogenesis via targeting AKT2 pathway. Theranostics. 4: 1193-208. PMID 25285168 DOI: 10.7150/thno.8712  1
2014 Hu Y, Wang J, Qian J, Kong X, Tang J, Wang Y, Chen H, Hong J, Zou W, Chen Y, Xu J, Fang JY. Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer. Cancer Research. 74: 6890-902. PMID 25277524 DOI: 10.1158/0008-5472.CAN-14-0686  1
2014 Wan S, Zhao E, Kryczek I, Vatan L, Sadovskaya A, Ludema G, Simeone DM, Zou W, Welling TH. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology. 147: 1393-404. PMID 25181692 DOI: 10.1053/j.gastro.2014.08.039  0.56
2014 Wang M, Wang J, Kong X, Chen H, Wang Y, Qin M, Lin Y, Chen H, Xu J, Hong J, Chen YX, Zou W, Fang JY. MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8. Scientific Reports. 4: 6145. PMID 25174450 DOI: 10.1038/srep06145  1
2014 Sun T, Du W, Xiong H, Yu Y, Weng Y, Ren L, Zhao H, Wang Y, Chen Y, Xu J, Xiang Y, Qin W, Cao W, Zou W, Chen H, et al. TMEFF2 deregulation contributes to gastric carcinogenesis and indicates poor survival outcome. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4689-704. PMID 24987055 DOI: 10.1158/1078-0432.CCR-14-0315  1
2014 Kryczek I, Lin Y, Nagarsheth N, Peng D, Zhao L, Zhao E, Vatan L, Szeliga W, Dou Y, Owens S, Zgodzinski W, Majewski M, Wallner G, Fang J, Huang E, ... Zou W, et al. IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L. Immunity. 40: 772-84. PMID 24816405 DOI: 10.1016/j.immuni.2014.03.010  1
2013 Maj T, Wei S, Welling T, Zou W. T cells and costimulation in cancer. Cancer Journal (Sudbury, Mass.). 19: 473-82. PMID 24270346 DOI: 10.1097/PPO.0000000000000002  0.36
2013 Kong X, Qian J, Chen LS, Wang YC, Wang JL, Chen H, Weng YR, Zhao SL, Hong J, Chen YX, Zou W, Xu J, Fang JY. Synbindin in extracellular signal-regulated protein kinase spatial regulation and gastric cancer aggressiveness. Journal of the National Cancer Institute. 105: 1738-49. PMID 24104608 DOI: 10.1093/jnci/djt271  1
2013 Sun X, Zhang M, El-Zataari M, Owyang SY, Eaton KA, Liu M, Chang YM, Zou W, Kao JY. TLR2 mediates Helicobacter pylori-induced tolerogenic immune response in mice. Plos One. 8: e74595. PMID 24058595 DOI: 10.1371/journal.pone.0074595  1
2013 Cui TX, Kryczek I, Zhao L, Zhao E, Kuick R, Roh MH, Vatan L, Szeliga W, Mao Y, Thomas DG, Kotarski J, Tarkowski R, Wicha M, Cho K, Giordano T, ... ... Zou W, et al. Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. Immunity. 39: 611-21. PMID 24012420 DOI: 10.1016/j.immuni.2013.08.025  1
2013 Chang J, Liu F, Lee M, Wu B, Ting K, Zara JN, Soo C, Al Hezaimi K, Zou W, Chen X, Mooney DJ, Wang CY. NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation. Proceedings of the National Academy of Sciences of the United States of America. 110: 9469-74. PMID 23690607 DOI: 10.1073/pnas.1300532110  1
2013 Lin YW, Ren LL, Xiong H, Du W, Yu YN, Sun TT, Weng YR, Wang ZH, Wang JL, Wang YC, Cui Y, Sun DF, Han ZG, Shen N, Zou W, et al. Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer. The Journal of Pathology. 230: 277-90. PMID 23424038 DOI: 10.1002/path.4179  1
2013 Wei S, Egenti MU, Teitz-Tennenbaum S, Zou W, Chang AE. Effects of tumor irradiation on host T-regulatory cells and systemic immunity in the context of adoptive T-cell therapy in mice. Journal of Immunotherapy (Hagerstown, Md. : 1997). 36: 124-32. PMID 23377667 DOI: 10.1097/CJI.0b013e31828298e6  1
2012 Welling TH, Fu S, Wan S, Zou W, Marrero JA. Elevated serum IL-8 is associated with the presence of hepatocellular carcinoma and independently predicts survival. Cancer Investigation. 30: 689-97. PMID 23072563 DOI: 10.3109/07357907.2012.732161  1
2012 Zou W, Restifo NP. Nine lives for TH9s? Nature Medicine. 18: 1177-8. PMID 22869182 DOI: 10.1038/nm.2868  1
2012 Wei S, Zhao E, Kryczek I, Zou W. Th17 cells have stem cell-like features and promote long-term immunity. Oncoimmunology. 1: 516-519. PMID 22754771  0.56
2012 Zhao E, Wang L, Dai J, Kryczek I, Wei S, Vatan L, Altuwaijri S, Sparwasser T, Wang G, Keller ET, Zou W. Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer. Oncoimmunology. 1: 152-161. PMID 22720236 DOI: 10.4161/onci.1.2.18480  0.56
2012 Li H, Wu K, Tao K, Chen L, Zheng Q, Lu X, Liu J, Shi L, Liu C, Wang G, Zou W. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology (Baltimore, Md.). 56: 1342-51. PMID 22505239 DOI: 10.1002/hep.25777  0.36
2012 Tanikawa T, Wilke CM, Kryczek I, Chen GY, Kao J, Núñez G, Zou W. Interleukin-10 ablation promotes tumor development, growth, and metastasis. Cancer Research. 72: 420-9. PMID 22123924 DOI: 10.1158/0008-5472.CAN-10-4627  1
2012 Zhao E, Xu H, Wang L, Kryczek I, Wu K, Hu Y, Wang G, Zou W. Bone marrow and the control of immunity. Cellular & Molecular Immunology. 9: 11-9. PMID 22020068 DOI: 10.1038/cmi.2011.47  0.56
2012 Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. International Journal of Cancer. 130: 29-39. PMID 21480217 DOI: 10.1002/ijc.25967  0.56
2011 Wilke CM, Wang L, Wei S, Kryczek I, Huang E, Kao J, Lin Y, Fang J, Zou W. Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease. Journal of Translational Medicine. 9: 217. PMID 22176654 DOI: 10.1186/1479-5876-9-217  1
2011 Kryczek I, Zhao E, Liu Y, Wang Y, Vatan L, Szeliga W, Moyer J, Klimczak A, Lange A, Zou W. Human TH17 cells are long-lived effector memory cells. Science Translational Medicine. 3: 104ra100. PMID 21998407 DOI: 10.1126/scitranslmed.3002949  0.56
2011 Wilke CM, Bishop K, Fox D, Zou W. Deciphering the role of Th17 cells in human disease. Trends in Immunology. 32: 603-11. PMID 21958759 DOI: 10.1016/j.it.2011.08.003  1
2011 Wilke CM, Wei S, Wang L, Kryczek I, Kao J, Zou W. Dual biological effects of the cytokines interleukin-10 and interferon-γ. Cancer Immunology, Immunotherapy : Cii. 60: 1529-41. PMID 21918895 DOI: 10.1007/s00262-011-1104-5  1
2011 Wei H, Wei S, Gan B, Peng X, Zou W, Guan JL. Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes & Development. 25: 1510-27. PMID 21764854 DOI: 10.1101/gad.2051011  0.36
2011 Wilke CM, Kryczek I, Zou W. Antigen-presenting cell (APC) subsets in ovarian cancer. International Reviews of Immunology. 30: 120-6. PMID 21557638 DOI: 10.3109/08830185.2011.567362  1
2011 Kryczek I, Wu K, Zhao E, Wei S, Vatan L, Szeliga W, Huang E, Greenson J, Chang A, Roliński J, Radwan P, Fang J, Wang G, Zou W. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. Journal of Immunology (Baltimore, Md. : 1950). 186: 4388-95. PMID 21357259 DOI: 10.4049/jimmunol.1003251  0.56
2011 Wilke CM, Zou W. T lymphocytes to IDO+ cells: check. Blood. 117: 2082-3. PMID 21330479 DOI: 10.1182/blood-2010-12-322172  1
2011 Wilke CM, Kryczek I, Wei S, Zhao E, Wu K, Wang G, Zou W. Th17 cells in cancer: help or hindrance? Carcinogenesis. 32: 643-9. PMID 21304053 DOI: 10.1093/carcin/bgr019  1
2010 Tawara I, Shlomchik WD, Jones A, Zou W, Nieves E, Liu C, Toubai T, Duran-Struuck R, Sun Y, Clouthier SG, Evers R, Lowler KP, Levy RB, Reddy P. A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 185: 3866-72. PMID 20810991 DOI: 10.4049/jimmunol.1001625  1
2010 Wilke CM, Wu K, Zhao E, Wang G, Zou W. Prognostic significance of regulatory T cells in tumor. International Journal of Cancer. Journal International Du Cancer. 127: 748-58. PMID 20473951 DOI: 10.1002/ijc.25464  1
2010 Zou W, Restifo NP. T(H)17 cells in tumour immunity and immunotherapy. Nature Reviews. Immunology. 10: 248-56. PMID 20336152 DOI: 10.1038/nri2742  1
2010 Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, Liu M, Eaton KA, Zou W, Berndt BE, Cole TS, Takeuchi T, Owyang SY, Luther J. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology. 138: 1046-54. PMID 19931266 DOI: 10.1053/j.gastro.2009.11.043  1
2009 Wu K, Kryczek I, Chen L, Zou W, Welling TH. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. Cancer Research. 69: 8067-75. PMID 19826049 DOI: 10.1158/0008-5472.CAN-09-0901  0.56
2009 Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH, Chang A, Coukos G, Liu R, Zou W. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood. 114: 1141-9. PMID 19470694 DOI: 10.1182/blood-2009-03-208249  0.56
2009 Kryczek I, Liu R, Wang G, Wu K, Shu X, Szeliga W, Vatan L, Finlayson E, Huang E, Simeone D, Redman B, Welling TH, Chang A, Zou W. FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Research. 69: 3995-4000. PMID 19383912 DOI: 10.1158/0008-5472.CAN-08-3804  0.56
2009 Kryczek I, Wei S, Szeliga W, Vatan L, Zou W. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood. 114: 357-9. PMID 19289853 DOI: 10.1182/blood-2008-09-177360  0.56
2009 Ruter J, Barnett BG, Kryczek I, Brumlik MJ, Daniel BJ, Coukos G, Zou W, Curiel TJ. Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines. Frontiers in Bioscience (Landmark Edition). 14: 1761-70. PMID 19273160 DOI: 10.2741/3338  1
2008 Kryczek I, Wei S, Gong W, Shu X, Szeliga W, Vatan L, Chen L, Wang G, Zou W. Cutting edge: IFN-gamma enables APC to promote memory Th17 and abate Th1 cell development. Journal of Immunology (Baltimore, Md. : 1950). 181: 5842-6. PMID 18941172  0.56
2008 Kryczek I, Bruce AT, Gudjonsson JE, Johnston A, Aphale A, Vatan L, Szeliga W, Wang Y, Liu Y, Welling TH, Elder JT, Zou W. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. Journal of Immunology (Baltimore, Md. : 1950). 181: 4733-41. PMID 18802076  1
2008 Wei S, Shreiner AB, Takeshita N, Chen L, Zou W, Chang AE. Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta. Cancer Research. 68: 5432-8. PMID 18593946 DOI: 10.1158/0008-5472.CAN-07-6598  1
2008 Wei S, Curiel T, Coukos G, Liu R, Zou W. Inhibitory B7 family members in human ovarian carcinoma. Advances in Experimental Medicine and Biology. 622: 261-71. PMID 18546634 DOI: 10.1007/978-0-387-68969-2_21  0.36
2008 Barnett BG, Rüter J, Kryczek I, Brumlik MJ, Cheng PJ, Daniel BJ, Coukos G, Zou W, Curiel TJ. Regulatory T cells: a new frontier in cancer immunotherapy. Advances in Experimental Medicine and Biology. 622: 255-60. PMID 18546633 DOI: 10.1007/978-0-387-68969-2_20  1
2007 Reddy P, Zou W. Blocking HDACs boosts regulatory T cells. Nature Medicine. 13: 1282-4. PMID 17987020 DOI: 10.1038/nm1107-1282  1
2007 Wei S, Daniel BJ, Brumlik MJ, Burow ME, Zou W, Khan IA, Wadsworth S, Siekierka J, Curiel TJ. Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection. Antimicrobial Agents and Chemotherapy. 51: 4324-8. PMID 17923491 DOI: 10.1128/AAC.00680-07  0.36
2007 Kryczek I, Wei S, Zhu G, Myers L, Mottram P, Cheng P, Chen L, Coukos G, Zou W. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Research. 67: 8900-5. PMID 17875732 DOI: 10.1158/0008-5472.CAN-07-1866  0.56
2007 Wei S, Kryczek I, Edwards RP, Zou L, Szeliga W, Banerjee M, Cost M, Cheng P, Chang A, Redman B, Herberman RB, Zou W. Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma. Cancer Research. 67: 7487-94. PMID 17671219 DOI: 10.1158/0008-5472.CAN-07-0565  1
2007 Kryczek I, Wei S, Vatan L, Escara-Wilke J, Szeliga W, Keller ET, Zou W. Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. Journal of Immunology (Baltimore, Md. : 1950). 179: 1423-6. PMID 17641006  0.56
2007 Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, Chang A, Zou W. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment Journal of Immunology. 178: 6730-6733. PMID 17513719  1
2007 Kryczek I, Wei S, Keller E, Liu R, Zou W. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. American Journal of Physiology. Cell Physiology. 292: C987-95. PMID 16943240 DOI: 10.1152/ajpcell.00406.2006  0.56
2006 Kryczek I, Wei S, Zou L, Zhu G, Mottram P, Xu H, Chen L, Zou W. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. Journal of Immunology (Baltimore, Md. : 1950). 177: 40-4. PMID 16785496  0.56
2006 Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P, Brumlik M, Cheng P, Curiel T, Myers L, Lackner A, Alvarez X, Ochoa A, Chen L, Zou W. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. The Journal of Experimental Medicine. 203: 871-81. PMID 16606666 DOI: 10.1084/jem.20050930  1
2006 Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nature Reviews. Immunology. 6: 295-307. PMID 16557261 DOI: 10.1038/nri1806  1
2006 Wei S, Kryczek I, Zou W. Regulatory T-cell compartmentalization and trafficking. Blood. 108: 426-31. PMID 16537800 DOI: 10.1182/blood-2006-01-0177  0.56
2005 Wei S, Kryczek I, Zou L, Curiel T, Cheng P, Zou W. Novel tumor immunotherapy: Targeting dysfunctional antigen presenting cells. Discovery Medicine. 5: 489-92. PMID 20704848  0.56
2005 Barnett B, Kryczek I, Cheng P, Zou W, Curiel TJ. Regulatory T cells in ovarian cancer: biology and therapeutic potential. American Journal of Reproductive Immunology (New York, N.Y. : 1989). 54: 369-77. PMID 16305662 DOI: 10.1111/j.1600-0897.2005.00330.x  0.56
2005 Kryczek I, Frydman N, Gaudin F, Krzysiek R, Fanchin R, Emilie D, Chouaib S, Zou W, Machelon V. The chemokine SDF-1/CXCL12 contributes to T lymphocyte recruitment in human pre-ovulatory follicles and coordinates with lymphocytes to increase granulosa cell survival and embryo quality. American Journal of Reproductive Immunology (New York, N.Y. : 1989). 54: 270-83. PMID 16212649 DOI: 10.1111/j.1600-0897.2005.00307.x  0.56
2005 Wei S, Kryczek I, Zou L, Daniel B, Cheng P, Mottram P, Curiel T, Lange A, Zou W. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Research. 65: 5020-6. PMID 15958543 DOI: 10.1158/0008-5472.CAN-04-4043  0.56
2005 Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Reviews. Cancer. 5: 263-74. PMID 15776005 DOI: 10.1038/nrc1586  1
2005 Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, Hogan M, Moons L, Wei S, Zou L, Machelon V, Emilie D, Terrassa M, Lackner A, Curiel TJ, Carmeliet P, ... Zou W, et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Research. 65: 465-72. PMID 15695388  0.56
2004 Zou L, Barnett B, Safah H, Larussa VF, Evdemon-Hogan M, Mottram P, Wei S, David O, Curiel TJ, Zou W. Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Research. 64: 8451-5. PMID 15548717 DOI: 10.1158/0008-5472.CAN-04-1987  0.36
2004 Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, ... ... Zou W, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Medicine. 10: 942-9. PMID 15322536 DOI: 10.1038/nm1093  1
2004 Curiel TJ, Cheng P, Mottram P, Alvarez X, Moons L, Evdemon-Hogan M, Wei S, Zou L, Kryczek I, Hoyle G, Lackner A, Carmeliet P, Zou W. Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Research. 64: 5535-8. PMID 15313886 DOI: 10.1158/0008-5472.CAN-04-1272  1
2003 Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, Krzysiek R, Knutson KL, Daniel B, Zimmermann MC, David O, Burow M, Gordon A, Dhurandhar N, Myers L, ... ... Zou W, et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nature Medicine. 9: 562-7. PMID 12704383 DOI: 10.1038/nm863  1
2002 Wei S, Marches F, Borvak J, Zou W, Channon J, White M, Radke J, Cesbron-Delauw MF, Curiel TJ. Toxoplasma gondii-infected human myeloid dendritic cells induce T-lymphocyte dysfunction and contact-dependent apoptosis. Infection and Immunity. 70: 1750-60. PMID 11895936  0.36
Show low-probability matches.